{"product_id":"from-financialisation-to-innovation-in-uk-big-pharma-cambridge-university-press-9781009278164-astrazeneca-and-glaxosmithkline-ner-tulum","title":"From Financialisation to Innovation in UK Big Pharma","description":"\u003cp\u003eDiscover the intricate relationship between innovation and financialisation in the UK pharmaceutical sector with \u003cstrong\u003eFrom Financialisation to Innovation in UK Big Pharma\u003c\/strong\u003e by Öner Tulum. Published by Cambridge University Press in 2022, this insightful work spans 75 pages and delves into the dynamics of major players like AstraZeneca and GlaxoSmithKline. Tulum's analysis sheds light on how financial strategies impact the drive for innovation within these pharmaceutical giants. This title is also available as Open Access on Cambridge Core, making it accessible for those eager to explore the evolving landscape of big pharma in the UK. Perfect for students, researchers, and industry professionals alike, this book is a must-read for anyone interested in the future of healthcare and pharmaceutical innovation.\u003c\/p\u003e","brand":"Öner Tulum","offers":[{"title":"Default Title","offer_id":52274190418262,"sku":"9781009278164","price":21.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0886\/3206\/6390\/files\/9781009278164.jpg?v=1767812182","url":"https:\/\/www.englishbook.fi\/products\/from-financialisation-to-innovation-in-uk-big-pharma-cambridge-university-press-9781009278164-astrazeneca-and-glaxosmithkline-ner-tulum","provider":"Bookshop","version":"1.0","type":"link"}